EPIRUS Biopharma
manufactures and commercialize biosimilar monoclonal antibodies. .. Read moreEPIRUS Biopharma
manufactures and commercialize biosimilar monoclonal antibodies. .. Read more
CEO
Add
06/2011
PrivateIndependent Company
News
Jun 19, 2020
Zolmax News
EPIRUS Biopharma: Financial Review: Epirus Biopharmaceuticals (OTCMKTS:EPRSQ) versus Synlogic (OTCMKTS:SYBX)
Jul 31, 2016
4-traders
EPIRUS Biopharma: EPIRUS BIOPHARMACEUTICALS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
Jul 27, 2016
BioPharma-Reporter
EPIRUS Biopharma: Epirus files for bankruptcy protection and hands Remicade biosim to Reliance Life Sciences
Jul 25, 2016
Reuters
EPIRUS Biopharma: BRIEF-Epirus Biopharmaceuticals entered settlement satisfaction amendment with Livzon Mabpharm
Jul 24, 2016
The Economic Times
EPIRUS Biopharma: Reliance Life gains global rights for copies of Infliximab
Jul 14, 2016
Business Wire
Press Release: EPIRUS Biopharma : Systemic Idiopathic Juvenile Arthritis Therapeutics Pipeline Report 2016 - Research and Markets
Jul 01, 2016
NewsMaker
Press Release: EPIRUS Biopharma :
Polyarticular Juvenile Idiopathic Arthritis (PJIA) Therapeutics & Drugs Pipeline Review 2016
Jun 24, 2016
Equities
EPIRUS Biopharma: Epirus Biopharmaceuticals, Inc. Files SEC Form 8-K, Current Report (Jun. 14, 2016)
Jun 15, 2016
Sonoran Weekly Review
EPIRUS Biopharma: EPIRUS Biopharmaceuticals To Sell EPIRUS Netherlands to Polpharma (NASDAQ:EPRS)
Jun 14, 2016
BioPharma-Reporter
EPIRUS Biopharma: Cash-strapped Epirus to sell CHO platform and biosimilar IP to Polpharma for $3.5m
EPIRUS Biopharma Competitors
1
2
3
4
5
6
7
8
9
10